{
    "clinical_study": {
        "@rank": "121193", 
        "arm_group": [
            {
                "arm_group_label": "Healthy", 
                "description": "Healthy subjects with no pain.\nRadioactive dye\nPET/MRI\nBlood draw"
            }, 
            {
                "arm_group_label": "Sciatica", 
                "description": "Subjects with sciatica and scheduled for an epidural steroid injection (ESI).\nRadioactive dye\nPET/MRI\nBlood draw"
            }
        ], 
        "biospec_descr": {
            "textblock": "A blood sample will be drawn for genotyping.  Genotyping will identify if the subject makes\n      proteins that will bind the radioactive tracer."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to see if the spine shows areas of inflammation using a\n      specific type of imaging (pictures)."
        }, 
        "brief_title": "PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Sciatica", 
        "condition_browse": {
            "mesh_term": [
                "Inflammation", 
                "Sciatica"
            ]
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to determine if inflammation around the spinal nerves can be\n      identified using a radioactive tracer [11C] PBR28 and integrated PET/MRI scan for the\n      purpose of better treating patients who have radicular lumbar pain with epidural steroid\n      injections."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria for pain subjects:\n\n          1. Subject is 18-75 years old.\n\n          2. Subject is able to give written informed consent.\n\n          3. Subject is currently diagnosed with lower extremity radicular pain regardless of\n             specific or suspected etiologies.\n\n          4. Subject has a clear dermatomal distribution of the painful area extending to the\n             distal lower extremities.\n\n          5. Subject reports ongoing pain intensity of 4 or greater using the visual analogue\n             scale (VAS) during the week prior to enrollment.\n\n          6. Subject is planning treatment with an epidural steroid injection (ESI) within 6\n             weeks.\n\n        Inclusion criteria for healthy subjects:\n\n          1. Subject is 18-75 years old.\n\n          2. Subject is able to give written informed consent.\n\n          3. Subject has no history of chronic back/spine pain.\n\n        Exclusion criteria for all groups:\n\n          1. Subject recently received a lumbar ESI (within 8 weeks).\n\n          2. Subject starts new NSAID medication for pain during the study.\n\n          3. Subject has predominantly axial low back pain.\n\n          4. Subject has known pain condition secondary to hip joint arthritis.\n\n          5. Subject is pregnant or breastfeeding.\n\n          6. Subject has allergy to lidocaine.\n\n          7. Subject is treated with chronic corticosteroid therapy.\n\n          8. Subject is on anticoagulation therapy (i.e. Coumadin, Plavix, or Lovenox).\n\n          9. Subject has a known bleeding disorder (i.e. hemophilia).\n\n         10. Subject has uncontrolled high blood pressure [>170/100].\n\n         11. Subject has a known heart condition.\n\n         12. Subject has known inflammatory disease (i.e. inflammatory bowel disease; ankylosing\n             spondylitis; etc.).\n\n         13. Subject has known liver dysfunction or renal insufficiency or impaired elimination\n             (Renal dysfunction is defined as eGFR < 60. Hepatic dysfunction is defined as LFTs \u2265\n             3x ULN).\n\n         14. Subject has been hospitalized recently (within one month) for a major psychiatric\n             disorder (i.e. major depression, bipolar disorder, schizophrenia, anxiety disorder,\n             or psychosis).\n\n         15. Subject has contraindications to MRI and PET scanning (i.e. presence of a cardiac\n             pacemaker or pacemaker wires, metallic particles in the body, vascular clips in the\n             head or previous neurosurgery, prosthetic heart valves, or claustrophobia).\n\n         16. Subject had research-related radiation exposure in the last 12 months.\n\n         17. Subject tests positive for use of illicit drugs, marijuana, or non-prescribed drugs."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "1. Patients who are receiving a lumbar ESI at a Partners affiliated clinic to treat\n             lower extremity radicular pain.\n\n          2. Healthy subjects with no pain from the local community."
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02130271", 
            "org_study_id": "2013P-002174"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Healthy", 
                    "Sciatica"
                ], 
                "description": "The radioactive dye [11C]PBR28 will be administered through an intravenous line (IV).", 
                "intervention_name": "Radioactive dye", 
                "intervention_type": "Drug", 
                "other_name": "[11C]PBR28"
            }, 
            {
                "arm_group_label": [
                    "Healthy", 
                    "Sciatica"
                ], 
                "description": "All subjects will undergo a simultaneous PET/MRI scan.  The scan will be up to 2 hours long.", 
                "intervention_name": "PET/MRI", 
                "intervention_type": "Radiation", 
                "other_name": "Integrated MR-PET 3 Tesla scanner (Siemens Biograph mMR)."
            }, 
            {
                "arm_group_label": [
                    "Healthy", 
                    "Sciatica"
                ], 
                "description": "Up to 11 tablespoons of blood will be drawn through an arterial line (A-line) for two purposes: 1) testing for the subject's genetic affinity to the radioactive dye, and 2) testing for the presence inflammatory biomarkers.", 
                "intervention_name": "Blood draw", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Sciatica", 
            "PET scan", 
            "MRI", 
            "Inflammation", 
            "Epidural Steroid Injection (ESI)"
        ], 
        "lastchanged_date": "May 1, 2014", 
        "link": {
            "description": "MGH Center for Translational Pain Research", 
            "url": "http://www2.massgeneral.org/painresearch/"
        }, 
        "location": {
            "contact": {
                "email": "mghpainresearch@partners.org", 
                "last_name": "MGH Center for Translational Pain Research", 
                "phone": "617-724-6102"
            }, 
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02114"
                }, 
                "name": "MGH Center for Translational Pain Research"
            }, 
            "investigator": {
                "last_name": "Yi Zhang, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients", 
        "overall_contact": {
            "email": "mghpainresearch@partners.org", 
            "last_name": "MGH Center for Translational Pain Research", 
            "phone": "617-724-6102"
        }, 
        "overall_official": {
            "affiliation": "Massachusetts General Hospital", 
            "last_name": "Yi Zhang, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The presence of inflammation in the spine using the radioactive tracer [11C]PBR28.", 
            "measure": "Inflammation in the spine", 
            "safety_issue": "No", 
            "time_frame": "2 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02130271"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Massachusetts General Hospital", 
            "investigator_full_name": "Yi Zhang, MD", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The subject's pain score (VAS) at baseline and up to 3 months after the ESI treatment.", 
            "measure": "Pain Scores on the Visual Analog Scale (VAS)", 
            "safety_issue": "No", 
            "time_frame": "up to 3 months"
        }, 
        "source": "Massachusetts General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Massachusetts General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}